Plain-English translation of NCT06083584 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing a new blood test called targeted RNA-Seq to help diagnose ALS. This test analyzes genetic material in your blood to find the specific cause of the disease, which could help doctors recommend targeted therapies tailored to your ALS type. The study aims to make ALS diagnosis faster and more accurate than current genetic testing methods.
Many people with ALS, especially those with a family history, never get a definitive genetic diagnosis using today's standard tests. This happens because either no genetic cause is found, or a genetic variation is found but doctors aren't sure if it actually causes ALS. The new blood test could solve this problem by looking at how genes are actually expressed in each patient's body, not just searching for known mutations.
You likely qualify if…
You likely don't qualify if…
You will donate a blood sample, which researchers will analyze using the new RNA-sequencing test. Depending on which group you're in, you may already have genetic test results on file, or you may be newly diagnosed with ALS. The study compares results across different patient groups—those with known genetic changes, those with uncertain genetic findings, and those with no genetic diagnosis yet—to validate whether the blood test works reliably.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
France